Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Paulson adds Kirkland Lake, exits Caesars in Q1 » 16:37
05/15/20
05/15
16:37
05/15/20
16:37
KL

Kirkland Lake Gold

$41.02 /

+0.91 (+2.27%)

, NAV

Navistar

$23.41 /

+0.77 (+3.40%)

, AEM

Agnico Eagle

$68.96 /

+2.88 (+4.36%)

, CZR

Caesars

$10.05 /

+0.185 (+1.88%)

, LOGM

LogMeln

$85.29 /

+0.23 (+0.27%)

, TIF

Tiffany

$127.06 /

-0.08 (-0.06%)

, TECD

Tech Data

$137.03 /

+0.03 (+0.02%)

, QEP

QEP Resources

$0.74 /

+0.0452 (+6.52%)

, ENDP

Endo

$3.81 /

-0.035 (-0.91%)

, NG

NovaGold

$11.71 /

+0.27 (+2.36%)

, GLD

SPDR Gold Shares

$163.95 /

+0.96 (+0.59%)

, DISCA

Discovery

$20.48 /

-0.07 (-0.34%)

, AU

AngloGold

$27.75 /

+1.71 (+6.57%)

, TSU

Tim Participacoes

$10.48 /

-0.38 (-3.50%)

, PCG

PG&E

$11.35 /

+0.245 (+2.21%)

, BHC

Bausch Health

$15.74 /

-0.2 (-1.25%)

, HZNP

Horizon Therapeutics

$47.07 /

+2.35 (+5.25%)

, TAK

Takeda Pharmaceutical

$18.60 /

-0.07 (-0.38%)

John Paulson's…

John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of March 31, 2020. The fund's two new buys during the first quarter included, by size of position, Kirkland Lake (KL) and Navistar (NAV). Paulson exited six holdings during the quarter, including by size of previous position Agnico Eagle Mines (AEM), Caesars (CZR), and LogMeIn (LOGM). The fund increased its stake in five holdings, including by size of previous position Tiffany (TIF), Tech Data (TECD), QEP Resources (QEP), Endo (ENDP), and Novagold (NG). Paulson reduced its stake in nine holdings, including by size of previous position SPDR Gold Shares (GLD), Discovery (DISCA), AngloGold Ashanti (AU), Tim Participacoes (TSU), and Pretium Resources (PVG). The fund's top holdings as of March 31, in order of size, were Bausch Health (BHC), SPDR Gold Shares, Horizon Therapeutics (HZNP), Takeda Pharmaceutical (TAK), and AngloGold Ashanti.

ShowHide Related Items >><<
TIF Tiffany
$127.06 /

-0.08 (-0.06%)

TECD Tech Data
$137.03 /

+0.03 (+0.02%)

TAK Takeda Pharmaceutical
$18.60 /

-0.07 (-0.38%)

QEP QEP Resources
$0.74 /

+0.0452 (+6.52%)

PCG PG&E
$11.35 /

+0.245 (+2.21%)

NG NovaGold
$11.71 /

+0.27 (+2.36%)

NAV Navistar
$23.41 /

+0.77 (+3.40%)

LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

HZNP Horizon Therapeutics
$47.07 /

+2.35 (+5.25%)

GLD SPDR Gold Shares
$163.95 /

+0.96 (+0.59%)

ENDP Endo
$3.81 /

-0.035 (-0.91%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

CZR Caesars
$10.05 /

+0.185 (+1.88%)

BHC Bausch Health
$15.74 /

-0.2 (-1.25%)

AU AngloGold
$27.75 /

+1.71 (+6.57%)

AEM Agnico Eagle
$68.96 /

+2.88 (+4.36%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

04/07/20 BofA
Kirkland Lake Gold initiated with a Buy at BofA
04/02/20 RBC Capital
RBC Capital maintains Outperform on Kirkland Lake Gold
03/24/20 Canaccord
Kirkland Lake Gold upgraded to Buy from Hold at Canaccord
03/18/20 CIBC
Kirkland Lake Gold upgraded to Outperformer from Neutral at CIBC
NAV Navistar
$23.41 /

+0.77 (+3.40%)

05/07/20 Longbow
Navistar likely to beat near-term expectations, says Longbow
04/17/20 JPMorgan
Truck cancellation rate in March hits high at 43%, says JPMorgan
04/03/20 JPMorgan
Class 8 truck orders dropped 51% in March, says JPMorgan
03/17/20 Baird
Baird says 'great opportunity' to get back involved with Navistar
AEM Agnico Eagle
$68.96 /

+2.88 (+4.36%)

05/01/20 TD Securities
Agnico Eagle price target lowered to C$76 from C$77 at TD Securities
05/01/20 BMO Capital
Agnico Eagle price target raised to C$60 from C$54 at BMO Capital
05/01/20 CIBC
CIBC backs Outperformer on Agnico Eagle after 'solid' Q1 results
05/01/20 RBC Capital
Agnico Eagle's Q1 results mixed relative to expectations, says RBC Capital
CZR Caesars
$10.05 /

+0.185 (+1.88%)

05/12/20 Deutsche Bank
Caesars price target lowered to $11 from $13 at Deutsche Bank
05/12/20 Jefferies
Eldorado Resorts price target raised to $38 from $29 at Jefferies
04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/17/20 SunTrust
Caesars upgraded to Buy from Hold at SunTrust
LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

01/15/20 Piper Sandler
Piper introduces long VMware, short Juniper pair trade into Q4 results
01/03/20
Fly Intel: Top five analyst downgrades
01/03/20
LogMeln downgraded to Sector Weight from Overweight at KeyBanc
01/02/20 KeyBanc
LogMeln downgraded to Sector Weight from Overweight at KeyBanc
TIF Tiffany
$127.06 /

-0.08 (-0.06%)

12/09/19 Cowen
Tiffany downgraded to Market Perform from Outperform at Cowen
12/06/19
Fly Intel: Top five analyst downgrades
12/06/19 Loop Capital
Tiffany price target raised to $135 from $85 at Loop Capital
12/06/19 Credit Suisse
Tiffany's best path forward likely the LVMH deal, says Credit Suisse
TECD Tech Data
$137.03 /

+0.03 (+0.02%)

03/18/20 Northcoast
Tech Data upgraded to Buy from Neutral at Northcoast
12/10/19 Northcoast
Tech Data downgraded to Neutral from Buy at Northcoast
10/17/19 Loop Capital
Tech Data price target raised to $150 from $130 at Loop Capital
10/16/19 Stifel
Tech Data investors likely to want higher takeout price, says Stifel
QEP QEP Resources
$0.74 /

+0.0452 (+6.52%)

04/07/20 Scotiabank
QEP Resources downgraded to Underperform from Sector Perform at Scotiabank
03/31/20 Piper Sandler
QEP Resources downgraded to Underweight from Neutral at Piper Sandler
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
QEP Resources downgraded to Equal Weight from Overweight at Stephens
ENDP Endo
$3.81 /

-0.035 (-0.91%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
NG NovaGold
$11.71 /

+0.27 (+2.36%)

GLD SPDR Gold Shares
$163.95 /

+0.96 (+0.59%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

05/14/20 Barrington
Discovery price target lowered to $28 from $34 at Barrington
04/27/20 RBC Capital
Discovery initiated with an Outperform at RBC Capital
04/23/20 Evercore ISI
Discovery downgraded to In Line from Outperform at Evercore ISI
04/17/20 Citi
Discovery price target lowered to $27 from $39 at Citi
AU AngloGold
$27.75 /

+1.71 (+6.57%)

04/21/20 BofA
AngloGold upgraded to Neutral from Underperform at BofA
02/06/20 UBS
AngloGold initiated with a Neutral at UBS
10/18/19 Goldman Sachs
AngloGold upgraded to Buy from Neutral at Goldman Sachs
06/27/19 BMO Capital
AngloGold upgraded to Outperform from Market Perform at BMO Capital
TSU Tim Participacoes
$10.48 /

-0.38 (-3.50%)

04/21/20 HSBC
Tim Participacoes upgraded to Hold from Reduce at HSBC
01/24/20 HSBC
Tim Participacoes downgraded to Reduce from Hold at HSBC
08/01/19 Barclays
Barclays upgrades Tim Participacoes to Overweight, downgrades Telefonica Brasil
08/01/19 Barclays
Tim Participacoes upgraded to Overweight from Equal Weight at Barclays
PCG PG&E
$11.35 /

+0.245 (+2.21%)

05/15/20 Barclays
Barclays upgrades Utilities sector along with PG&E and two others
05/15/20 Barclays
PG&E upgraded to Overweight from Equal Weight at Barclays
05/06/20 Mizuho
PG&E price target raised to $13.50 from $12.50 at Mizuho
05/04/20
Fly Intel: Top five analyst upgrades
BHC Bausch Health
$15.74 /

-0.2 (-1.25%)

04/24/20 Citi
Bausch Health initiated with a Buy at Citi
04/02/20 Morgan Stanley
Bausch Health downgraded to Equal Weight with $17 price target at Morgan Stanley
04/02/20 Morgan Stanley
Bausch Health downgraded to Equal Weight from Overweight at Morgan Stanley
HZNP Horizon Therapeutics
$47.07 /

+2.35 (+5.25%)

05/08/20 Morgan Stanley
Horizon Therapeutics price target raised to $50 from $39 at Morgan Stanley
04/14/20 Piper Sandler
Horizon Therapeutics risk/reward profile 'highly attractive,' says Piper Sandler
02/21/20 Cantor Fitzgerald
Selecta positioned for 50%-100% rally on positive data, says Cantor Fitzgerald
01/22/20 BMO Capital
Horizon Therapeutics price target raised to $46 from $40 at BMO Capita
TAK Takeda Pharmaceutical
$18.60 /

-0.07 (-0.38%)

04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
03/25/20 Stifel
Molecular Templates initiated with a Buy at Stifel
02/25/20 Stifel
Iovance among 'more interesting' cell therapy takeout candidates, says Stifel
TIF Tiffany
$127.06 /

-0.08 (-0.06%)

TECD Tech Data
$137.03 /

+0.03 (+0.02%)

TAK Takeda Pharmaceutical
$18.60 /

-0.07 (-0.38%)

QEP QEP Resources
$0.74 /

+0.0452 (+6.52%)

PCG PG&E
$11.35 /

+0.245 (+2.21%)

NAV Navistar
$23.41 /

+0.77 (+3.40%)

LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

HZNP Horizon Therapeutics
$47.07 /

+2.35 (+5.25%)

ENDP Endo
$3.81 /

-0.035 (-0.91%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

CZR Caesars
$10.05 /

+0.185 (+1.88%)

BHC Bausch Health
$15.74 /

-0.2 (-1.25%)

AEM Agnico Eagle
$68.96 /

+2.88 (+4.36%)

TIF Tiffany
$127.06 /

-0.08 (-0.06%)

TECD Tech Data
$137.03 /

+0.03 (+0.02%)

TAK Takeda Pharmaceutical
$18.60 /

-0.07 (-0.38%)

PCG PG&E
$11.35 /

+0.245 (+2.21%)

NAV Navistar
$23.41 /

+0.77 (+3.40%)

LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

ENDP Endo
$3.81 /

-0.035 (-0.91%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

CZR Caesars
$10.05 /

+0.185 (+1.88%)

TIF Tiffany
$127.06 /

-0.08 (-0.06%)

TECD Tech Data
$137.03 /

+0.03 (+0.02%)

QEP QEP Resources
$0.74 /

+0.0452 (+6.52%)

PCG PG&E
$11.35 /

+0.245 (+2.21%)

NAV Navistar
$23.41 /

+0.77 (+3.40%)

LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

ENDP Endo
$3.81 /

-0.035 (-0.91%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

CZR Caesars
$10.05 /

+0.185 (+1.88%)

BHC Bausch Health
$15.74 /

-0.2 (-1.25%)

TIF Tiffany
$127.06 /

-0.08 (-0.06%)

TAK Takeda Pharmaceutical
$18.60 /

-0.07 (-0.38%)

PCG PG&E
$11.35 /

+0.245 (+2.21%)

NG NovaGold
$11.71 /

+0.27 (+2.36%)

LOGM LogMeln
$85.29 /

+0.23 (+0.27%)

KL Kirkland Lake Gold
$41.02 /

+0.91 (+2.27%)

GLD SPDR Gold Shares
$163.95 /

+0.96 (+0.59%)

ENDP Endo
$3.81 /

-0.035 (-0.91%)

DISCA Discovery
$20.48 /

-0.07 (-0.34%)

CZR Caesars
$10.05 /

+0.185 (+1.88%)

BHC Bausch Health
$15.74 /

-0.2 (-1.25%)

AEM Agnico Eagle
$68.96 /

+2.88 (+4.36%)

GLD SPDR Gold Shares
$163.95 /

+0.96 (+0.59%)

Hot Stocks
Endo up 6% after reporting Q1 results  08:25
05/07/20
05/07
08:25
05/07/20
08:25
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

 
ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Hot Stocks
Endo reports Q1 International Pharmaceuticals segment revenue $29M » 08:24
05/07/20
05/07
08:24
05/07/20
08:24
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

Q1 International…

Q1 International Pharmaceuticals segment revenues of $29 million were comparable to the same period in the prior year.

ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Hot Stocks
Endo reports Q1 Generic Pharmaceuticals revenue $251M vs. $219M last year » 08:24
05/07/20
05/07
08:24
05/07/20
08:24
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

Q1 Generic…

Q1 Generic Pharmaceuticals segment revenues were $251 million, an increase of 15% compared to $219 million in first-quarter 2019. This increase was primarily attributable to recent product launches and accelerated prescription fulfillment resulting from consumer access concerns related to the COVID-19 pandemic and was partially offset by continued competitive pressure on commoditized generic products. During first-quarter 2020, the Generic Pharmaceuticals segment launched four products.

ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Hot Stocks
Endo reports Q1 Sterile Injectables segment revenue $336M vs. $270M last year » 08:22
05/07/20
05/07
08:22
05/07/20
08:22
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

Q1 Sterile Injectables…

Q1 Sterile Injectables segment revenues were $336 million, an increase of 25% compared to $270 million in first-quarter 2019. This increase reflects the strong growth of VASOSTRICT and ADRENALIN resulting primarily from significantly increased sales volume towards the end of the quarter due to higher utilization primarily to treat patients infected with COVID-19, increased channel inventory stocking and price.

ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Hot Stocks
Endo reports Q1 Branded Pharmaceuticals segment revenues $204M » 08:21
05/07/20
05/07
08:21
05/07/20
08:21
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

Q1 Branded…

Q1 Branded Pharmaceuticals segment revenues of $204 million were comparable to the same period in the prior year. Continued strong growth in the segment's Specialty Products portfolio was offset by ongoing generic competition in the segment's Established Products portfolio. Specialty Products revenues increased 17% to $134 million in first-quarter 2020 compared to $115 million in first-quarter 2019, primarily driven by the strong performance of XIAFLEX. Sales of XIAFLEX increased 30% to $89 million compared to $69 million in first-quarter 2019, which was primarily attributable to demand growth driven by continued commercial execution and investment in promotional activities as well as inventory stocking in the specialty pharmacy and specialty distributor channels.

ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Earnings
Endo reports Q1 adj. EPS 94c, consensus 54c » 06:07
05/07/20
05/07
06:07
05/07/20
06:07
ENDP

Endo

$4.20 /

+0.04 (+0.96%)

Reports Q1 revenue $820M,…

Reports Q1 revenue $820M, consensus $712.85M. "I am proud of the way Endo is responding to the challenges associated with the COVID-19 pandemic. We have taken appropriate steps to protect the health and safety of our nearly 3,200 team members and their families around the globe, to support our communities through monetary and product donations, and to rapidly increase the production and distribution of Endo's critical care products which are administered to patients suffering from COVID-19," said Blaise Coleman, President and CEO at Endo. Mr. Coleman continued, "Our first-quarter 2020 results reflect continued strong underlying performance from our Sterile Injectables segment and the Specialty Products Portfolio of our Branded Pharmaceuticals segment. Our results were significantly augmented by higher patient demand and increased customer inventory purchasing due to the COVID-19 pandemic. Although the future impact on our business from COVID-19 is uncertain, we will continue our commitments to keeping our team members safe, reliably supplying critical medicines to patients in need and investing for long term success."

ShowHide Related Items >><<
ENDP Endo
$4.20 /

+0.04 (+0.96%)

04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
Over a month ago
Initiation
Fly Intel: Top five analyst initiations » 10:08
04/24/20
04/24
10:08
04/24/20
10:08
RDUS

Radius Health

$16.89 /

-0.34 (-1.97%)

, QFIN

360 Finance

$7.46 /

+0.08 (+1.08%)

, AWK

American Water

$125.39 /

+0.46 (+0.37%)

, WTRG

Essential Utilities

$42.97 /

+0.34 (+0.80%)

, SJW

SJW Group

$57.74 /

-0.05 (-0.09%)

, ARW

Arrow Electronics

$53.98 /

+0.24 (+0.45%)

, AVT

Avnet

$27.29 /

+ (+0.00%)

, TEVA

Teva

$10.22 /

+0.05 (+0.49%)

, MNK

Mallinckrodt

$3.47 /

+0.015 (+0.43%)

, ENDP

Endo

$4.04 /

+0.27 (+7.16%)

, BHC

Bausch Health

$17.41 /

+1.09 (+6.68%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Radius Health (RDUS) initiated with a Hold at Stifel. 2. 360 Finance (QFIN) initiated with an Overweight at Morgan Stanley. 3. American Water (AWK), Essential Utilities (WTRG), and SJW Group (SJW) were initiated with an Outperform at RBC Capital. 4. Arrow Electronics (ARW) was initiated with a Buy at Loop Capital while Avnet (AVT) was initiated with a Hold. 5. Endo (ENDP) and Bausch Health (BHC) were initiated with a Buy at Citi, while Mallinckrodt (MNK) was initiated with a Sell, and Teva (TEVA) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RDUS Radius Health
$16.89 /

-0.34 (-1.97%)

04/23/20 Stifel
Radius Health initiated with a Hold at Stifel
04/23/20 Stifel
Radius Health initiated with a Hold at Stifel
11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
QFIN 360 Finance
$7.46 /

+0.08 (+1.08%)

04/24/20 Morgan Stanley
360 Finance initiated with an Overweight at Morgan Stanley
05/14/19 China Renaissance
360 Finance initiated with a Buy at China Renaissance
AWK American Water
$125.39 /

+0.46 (+0.37%)

04/24/20 RBC Capital
American Water initiated with an Outperform at RBC Capital
04/15/20 Goldman Sachs
American Water upgraded to Buy from Neutral at Goldman Sachs
02/20/20 Baird
American Water price target raised to $139 from $128 at Baird
02/20/20 Wells Fargo
American Water price target raised to $147 from $128 at Wells Fargo
WTRG Essential Utilities
$42.97 /

+0.34 (+0.80%)

04/24/20 RBC Capital
Essential Utilities initiated with an Outperform at RBC Capital
04/15/20 Goldman Sachs
Essential Utilities initiated with a Neutral at Goldman Sachs
SJW SJW Group
$57.74 /

-0.05 (-0.09%)

04/24/20 RBC Capital
SJW Group initiated with an Outperform at RBC Capital
11/15/19 JPMorgan
SJW Group initiated with a Neutral at JPMorgan
10/07/19
Fly Intel: Top five analyst initiations
10/07/19 Macquarie
SJW Corp. initiated with an Outperform rating at Macquarie
ARW Arrow Electronics
$53.98 /

+0.24 (+0.45%)

04/24/20 Loop Capital
Arrow Electronics initiated with a Buy at Loop Capital
04/23/20 Loop Capital
Arrow Electronics initiated with a Buy at Loop Capital
04/14/20 Raymond James
Arrow Electronics downgraded to Market Perform from Outperform at Raymond James
03/20/20 Wells Fargo
Wells Fargo cuts price targets in IT Hardware & Communications Networking space
AVT Avnet
$27.29 /

+ (+0.00%)

04/24/20 Loop Capital
Avnet initiated with a Hold at Loop Capital
04/23/20 Loop Capital
Avnet initiated with a Hold at Loop Capital
03/19/20 Wells Fargo
Avnet upgraded to Equal Weight from Underweight at Wells Fargo
03/16/20 SunTrust
Avnet upgraded to Hold, Belden to Buy at SunTrust
TEVA Teva
$10.22 /

+0.05 (+0.49%)

04/24/20 Citi
Teva initiated with a Neutral at Citi
04/06/20 UBS
Teva upgraded to Buy from Neutral at UBS
03/23/20 SunTrust
SunTrust lowers price targets among Pharmaceuticals due to COVID-19
03/09/20 Oppenheimer
Amgen price target lowered to $250 from $256 at Oppenheimer
MNK Mallinckrodt
$3.47 /

+0.015 (+0.43%)

04/24/20 Citi
Mallinckrodt initiated with a Sell at Citi
02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
ENDP Endo
$4.04 /

+0.27 (+7.16%)

04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
07/15/19
Fly Intel: Top five analyst downgrades
BHC Bausch Health
$17.41 /

+1.09 (+6.68%)

04/24/20 Citi
Bausch Health initiated with a Buy at Citi
04/02/20 Morgan Stanley
Bausch Health downgraded to Equal Weight with $17 price target at Morgan Stanley
04/02/20 Morgan Stanley
Bausch Health downgraded to Equal Weight from Overweight at Morgan Stanley
03/26/20 Piper Sandler
Doctor survey shows 'massive' near-term COVID disruption, says Piper Sandler
Initiation
Endo initiated with a Buy at Citi » 06:25
04/24/20
04/24
06:25
04/24/20
06:25
ENDP

Endo

$3.77 /

+0.39 (+11.54%)

Citi analyst Navann Ty…

Citi analyst Navann Ty initiated coverage of Endo International with a Buy rating and $7 price target. The low opioid settlements so far and their rationale may help with Endo's future negotiations, Ty tells investors in a research note. The analyst recommends investors buy the stock for the company's progress in cellulite.

ShowHide Related Items >><<
ENDP Endo
$3.77 /

+0.39 (+11.54%)

01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
07/15/19
Fly Intel: Top five analyst downgrades
07/15/19 Morgan Stanley
Endo, Teva downgraded to Underweight on underappreciated risks at Morgan Stanley
Conference/Events
Cantor Fitzgerald biopharma analyst to hold analyst/industry conference call » 10:55
03/09/20
03/09
10:55
03/09/20
10:55
ENDP

Endo

$4.00 /

-0.6 (-13.04%)

, JNJ

Johnson & Johnson

$138.54 /

-3.59 (-2.53%)

, MNK

Mallinckrodt

$2.46 /

-0.47 (-16.04%)

, TEVA

Teva

$9.10 /

-1.19 (-11.56%)

Specialty Pharmaceuticals…

Specialty Pharmaceuticals Analyst Chen and Biopharma Analyst Folkes, along with Ilkiko Mehes, Pharmaceutical Industry Legal Advisor, discuss the opioid liabilities for Johnson & Johnson, Teva Pharma, Endo Pharma, Mallinckrodt and others, as well as a review of Purdue's opioid litigation and the potential for a universal settlement at a luncheon discussion being held in Boston on March 9 at 12 pm.

ShowHide Related Items >><<
ENDP Endo
$4.00 /

-0.6 (-13.04%)

01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
09/11/19 Guggenheim
Endo assumed with a Neutral at Guggenheim
07/15/19
Fly Intel: Top five analyst downgrades
07/15/19 Morgan Stanley
Endo, Teva downgraded to Underweight on underappreciated risks at Morgan Stanley
JNJ Johnson & Johnson
$138.54 /

-3.59 (-2.53%)

03/06/20 Credit Suisse
Johnson & Johnson price target lowered to $159 from $170 at Credit Suisse
03/04/20 Citi
Johnson & Johnson initiated with a Buy at Citi
03/02/20 Wells Fargo
Baxter, J&J best positioned to weather coronavirus spread, says Wells Fargo
01/27/20 Credit Suisse
Johnson & Johnson price target raised to $170 from $163 at Credit Suisse
MNK Mallinckrodt
$2.46 /

-0.47 (-16.04%)

02/25/20 Stifel
Mallinckrodt clearing path for shares to be revalued, says Stifel
01/22/20 Wells Fargo
Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo
09/10/19 Stifel
Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel
09/09/19 Stifel
Mallinckrodt price target lowered to $8 from $20 at Stifel
TEVA Teva
$9.10 /

-1.19 (-11.56%)

03/09/20 Oppenheimer
Amgen price target lowered to $250 from $256 at Oppenheimer
02/26/20 H.C. Wainwright
H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results
02/25/20 Wells Fargo
Emergent BioSolutions price target raised to $75 from $66 at Wells Fargo
02/24/20 Edward Jones
Teva downgraded to Sell from Hold at Edward Jones

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.